Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2431486 | 0.83 | LMNA (0.51) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL31601392 | 0.83 | LMNA (0.51) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL12519547 | 0.82 | ALOX15 (0.49) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL10684675 | 0.81 | SMN1; SMN2 (0.39) | TSHRKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL23091547 | 0.81 | TSHR (0.48) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL2122977 | 0.81 | TSHR (0.48) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL20562726 | 0.81 | ALOX15 (0.57) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL11337020 | 0.81 | TSHR (0.48) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL11340760 | 0.79 | TSHR (0.58) | TSHRALOX15MAPK1KMT2AMEN1 | |
| SCHEMBL22223246 | 0.79 | ALOX15 (0.47) | TSHRALOX15MAPK1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1364938-B1 | PROCESS FOR PRODUCING FLUORINE COMPOUND | ASAHI GLASS CO LTD (JP) | 2009-05-13 | — | — | EP | disclosed |
| CN-1231453-C | Process for producing fluorine-containing compound | ASAHI GLASS CO LTD (JP) | 2005-12-14 | — | — | CN | disclosed |
| US-6903230-B2 | Process for producing a fluorine-containing compound | ASAHI GLASS COMPANY, LIMITED (JP) | 2005-06-07 | — | — | US | disclosed |
| CN-1489572-A | Process for producing fluorine-containing compound | ������������ʽ���� | 2004-04-14 | — | — | CN | disclosed |
| US-20040024269-A1 | Process for producing a fluorine-containing compound | ASAHI GLASS COMPANY LIMITED (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1364938-A1 | PROCESS FOR PRODUCING FLUORINE COMPOUND | Asahi Glass Company, Limited (JP) | 2003-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024269-A1 | Process for producing a fluorine-containing compound | FOXO1, PFAS, PFKFB2 | TSHR 635/4885ALOX15 1293/4885MAPK1 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.